Contacts
Questions regarding responsiveness of the proposed studies to the BIQSFP should be directed to the one of the following NCI Program Staff:
For CTEP:
Margaret M. Mooney, M.D.
Chief
Clinical Investigations Branch
National Cancer Institute
Building EPN Room 7025
6130 Executive Blvd
Bethesda, MD 20892
Phone: 301-496-2522
Fax: 301-402-0557
Email: mooneym@ctep.nci.nih.gov
For DCP:
Worta J. McCaskill-Stevens, MD, MS
Acting Chief
Community Oncology and Prevention Trials Research Group
Head, Breast Cancer Prevention
Head, Minority-Based Community Clinical Oncology Program
Division of Cancer Prevention
6130 Executive Blvd., EPN 2026
Bethesda, Md. 20892
301-496-8541
301-496-8667
Email: wm57h@nih.gov
Ann M. O'Mara, Ph.D.
Program Director
Community Oncology and Prevention Trials Research Group
National Cancer Institute
Executive Plaza North Room 2017 - 7340
6130 Executive Blvd
Bethesda, MD 20892-7340
Phone: 301-496-8541
Fax: 301-496-8667
Email: omaraa@mail.nih.gov
Questions regarding cancer imaging studies:
Lalitha K. Shankar, MD, PhD
Chief, Clinical Trials Branch
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
6130 Executive Blvd., Room 6056
Bethesda, MD 20892-7412
Phone: 301-496-9531
Email: shankerl@mail.nih.gov
Questions regarding the prioritization, evaluation, and Administrative Supplements funding processes should be directed to:
Raymond A. Petryshyn, Ph.D.
Program Director
Coordinating Center for Clinical Trials
National Cancer Institute
Executive Plaza South Suite 300
6120 Executive Blvd
Bethesda, MD 20892
Phone: 301-594-1216
Fax: 301-480-0485
Email: petryshr@mail.nih.gov
Questions regarding the subcontracting process should be directed to:
Geoffrey D. Seidel, RN, BSN, MS (Contractor)
Clinical Project Manager II, Program Director
Support to Coordinating Center for Clinical Trials
National Cancer Institute, Office of the Director
Frederick National Laboratory for Cancer Research
Clinical Monitoring Research Program
National Cancer Institute at Frederick
National Institutes of Health
6120 Executive Boulevard, Suite 300
Bethesda, MD 20892-7227
O: 301-496-5748
F: 301-480-1522
Email: seidelg@mail.nih.gov
Questions regarding Cost-Effectiveness Analysis should be directed to:
O. Wolf Lindwasser, Ph.D.
Program Director
Coordinating Center for Clinical Trials
Office of the Director
National Cancer Institute
6120 Executive Blvd, Suite 300
Bethesda, MD 20892-7227 (mail)
Rockville, MD 20852 (courier)
O: 301-443-6792
F: 301-480-1522
Email: wolf.lindwasser@nih.gov
